NEUTRAL ALLOGRAFTS - LACK OF ALLOGENEIC STIMULATION BY CULTURED HUMAN-CELLS EXPRESSING MHC CLASS-I AND CLASS-II ANTIGENS

被引:52
作者
THEOBALD, VA [1 ]
LAUER, JD [1 ]
KAPLAN, FA [1 ]
BAKER, KB [1 ]
ROSENBERG, M [1 ]
机构
[1] ORGANOGENESIS INC,83 ROGERS ST,CAMBRIDGE,MA 02142
关键词
D O I
10.1097/00007890-199301000-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cultured human dermal fibroblasts, smooth muscle cells, epidermal cells and endothelial cells were tested for immunogenicity in an in vitro allostimulation assay. Gamma interferon was used to induce MHC class II expression, since these cells constitutively express class I but not class II antigens. In contrast to human dermal fibroblasts, smooth muscle cells and epidermal cells, endothelial cells, were able to stimulate a significant proliferative response in normal allogeneic lymphocytes. Since ICAM-1 was also expressed on these cells, this inability to initiate allostimulation was probably not due to the absence of adhesion molecules. Addition of exogenous cytokines such as IL-1, IL-2, and TNF did not restore T cell proliferation in the test system. Therefore the inability of dermal fibroblasts, smooth muscle cells, and epidermal cells to initiate significant allostimulation was also not due to lack of cytokine production. It appears that certain cells lack as-yet-undefined costimulatory factors required for their effective recognition as foreign. These results support the notion that cultured human fibroblasts, smooth muscle cells, and epidermal cells could serve as building blocks of engineered ''neutral allografts'' for use across MHC barriers.
引用
收藏
页码:128 / 133
页数:6
相关论文
共 33 条
[31]   MAJOR HISTOCOMPATIBILITY COMPLEX EXPRESSING NONHEMATOPOIETIC ASTROGLIAL CELLS PRIME ONLY CD8+ LYMPHOCYTE-T ASTROGLIAL CELLS AS PERPETUATORS BUT NOT INITIATORS OF CD4+ T-CELL RESPONSES IN THE CENTRAL-NERVOUS-SYSTEM [J].
SEDGWICK, JD ;
MOSSNER, R ;
SCHWENDER, S ;
MOSSNER, R ;
TERMEULEN, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1235-1246
[32]  
UMETSU DT, 1986, J IMMUNOL, V136, P440
[33]  
WEAVER CT, 1988, P NATL ACAD SCI USA, V85, P9699